The present authors executed an open up-label pilot study that administered psilocybin to 15 treatment method-resistant tobacco/nicotine-dependent people who smoke, during the context of cognitive behavioral therapy for smoking cessation [58]. Participants had been administered ~0.29 mg/kg oral psilocybin to the participant’s focus on day to Stop